An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01 for nasal tube feeding patients

An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01 for nasal tube feeding patients - An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036569

Enrollment

Registered

2019-04-22

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasal tube feeding patients

Interventions

Administered novel enteral nutrition VVT-01 for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects who receive transnasal nutrition. 2. Subjects who are 50 years or older. 3. Subjects who have an expectation to continue transnasal nutrition more than 1 month.

Exclusion criteria

Exclusion criteria: 1. Subjects who have serious disease such as liver, kidney, heart, lung, digestive, hematological and metabolic. 2. Subjects who have history of drug or serious food allergy. 3. Subjects who are participate in the other study about drug during the study period. 4. Subjects whose energy doses are not stable for the last 1 month. 5. Subjects judged inappropriate for the study by the investigator.

Design outcomes

Primary

Measure	Time frame
body weight	—

Secondary

Measure	Time frame
Digestive symptoms (diarrhea and vomiting frequency), defecation situation (defecation frequency and fecal condition), fever frequency, nutritional condition (serum albumin)	—

Countries

Japan

Contacts

Public ContactTakumi Serita

Michinoo hospital Psychiatry

dr-serita@michinoo.or.jp095-856-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026